Evidence map›Paper›PMID 37477595›Full record

ArticleBlood advances2023

Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome.

Yanna Ding, Alina E Dulau-Florea, Emma M Groarke, Bhavisha A Patel, David B Beck, Peter C Grayson, Marcela A Ferrada, Neal S Young, Katherine R Calvo, Raul C Braylan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yanna DingLaboratory of Pathology, Hematopathology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD.ORCID 0000-0003-1342-0912
Alina E Dulau-FloreaDepartment of Laboratory Medicine, Hematology Section, Clinical Center, Bethesda, MD.
Emma M GroarkeHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-4648-5926
Bhavisha A PatelHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
David B BeckCenter for Human Genetics and Genomics, New York University Grossman School of Medicine, New York, NY.
Peter C GraysonNational Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD.
Marcela A FerradaNational Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD.
Neal S YoungHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Katherine R CalvoDepartment of Laboratory Medicine, Hematology Section, Clinical Center, Bethesda, MD.
Raul C BraylanDepartment of Laboratory Medicine, Hematology Section, Clinical Center, Bethesda, MD.ORCID 0000-0001-6733-5161
National Institutes of Health · USNational Institutes of Health Clinical Center · USCenter for Human Genetics · USNational Cancer Institute · US

Funding

The Role of microRNA in Hematologic MalignanciesZIACL090025 · CLC · CLINICAL CENTER · PI CALVO, KATHERINE · 2010 to 2025
$0k
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37477595
PMCPMC10582370
OpenAlexW4384925248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.